IL1B and granular corneal dystrophy type II: Together, these data show that vaccination with either of the cVLP:IL-1β vaccines resulted in a reduction of local IL-1β levels as well as clinical symptoms induced in a mouse model of ACD, without reducing the local levels of other pro-inflammatory cytokines.